The β3 Adrenergic Receptor Agonist CL316243 Ameliorates the Metabolic Abnormalities of High-Fat Diet-Fed Rats by Activating AMPK/PGC-1α Signaling in Skeletal Muscle

The β3 Adrenergic Receptor Agonist CL316243 Ameliorates the Metabolic Abnormalities of High-Fat Diet-Fed Rats by Activating AMPK/PGC-1α Signaling in Skeletal Muscle

Li-Na Ding,1,* Ya Cheng,1,* Lu-Yao Xu,1 Le-Quan Zhou,1,2 Li Guan,1,2 Hai-Mei Liu,1,2 Ya-Xing Zhang,1,2 Run-Mei Li,1 Jin-Wen Xu1,2 1The Research Center of Basic Integrative Medicine, Basic Medical College, Guangzhou University of Chinese Medicine, University Town, Guangzhou, 510006, People’...

Full description

Bibliographic Details
Main Authors: Ding LN, Cheng Y, Xu LY, Zhou LQ, Guan L, Liu HM, Zhang YX, Li RM, Xu JW
Format: Article
Language:English
Published: Dove Medical Press 2021-03-01
Series:Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
Subjects:
cl316243
ampk
pgc-1α
l6 myotubes
carnitine palmitoyl transferase
Online Access:https://www.dovepress.com/the-beta3-adrenergic-receptor-agonist-cl316243-ameliorates-the-metabol-peer-reviewed-article-DMSO

Internet

https://www.dovepress.com/the-beta3-adrenergic-receptor-agonist-cl316243-ameliorates-the-metabol-peer-reviewed-article-DMSO

Similar Items